https://www.globenewswire.com/news-release/2024/07/08/2909715/0/en/Global-Venous-Thromboembolism-Treatment-Market-Set-for-Significant-Growth-Projected-to-Reach-USD-2-580-90-Million-by-2034-Future-Market-Insights-Inc.html
Breakthrough Innovations like Anticoagulant and Thrombolytic Therapy are Redefining the Landscape of Venous Thromboembolism Treatment. FMI forecasts...
venous thromboembolismmarket setglobaltreatment
https://pubmed.ncbi.nlm.nih.gov/29222259/
The management of superficial vein thrombosis (SVT) is poorly defined and remains controversial overall. SVT has long been considered a benign, self-limited...
venous thromboembolismcontroversiestreat
https://www.marketresearchfuture.com/reports/venous-thromboembolism-market-27947
Venous Thromboembolism Market share is projected to reach USD 1.114 Billion By 2035, at a 6.28% CAGR by driving industry size, top company analysis, segments...
venous thromboembolismmarket sizegrowth report
https://www.rti.org/publication/further-results-risk-nonfatal-venous-thromboembolism-users-contraceptive-transdermal-patch-compared
venous thromboembolismresultsrisk
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1394012/full
One of the main causes of unfavorable pregnancy outcomes in expectant mothers is pregnancyassociated venous thromboembolism. Although pregnancy-related venou...
venous thromboembolismfrontiersradiologicaldiagnosispregnancy
https://pubmed.ncbi.nlm.nih.gov/29995659/
: The current study aims to evaluate, for the first time in the Portuguese population, the association with venous thromboembolism (VTE) of five well known and...
venous thromboembolismriskassociatedabofgg
https://www.healio.com/news/orthopedics/20250108/surgery-at-high-altitude-may-be-a-risk-factor-for-venous-thromboembolism-in-patients
Published results showed patients who undergo total knee arthroplasty at an altitude of 4,000 feet or higher may be at increased risk for postoperative venous...
high altituderisk factorsurgerymay
https://www.pharmaceutical-technology.com/data-insights/regn-9933-regeneron-pharmaceuticals-venous-thromboembolism-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-225484&utm_campaign=recommended-articles-pi
REGN-9933 is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Venous Thromboembolism.
regeneron pharmaceuticalsvenous thromboembolismregnlikelihood
https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2024.1519869/full
BackgroundAnticoagulants are the primary means for the treatment and prevention of venous thromboembolism (VTE), but their clinical standardized application ...
venous thromboembolismfrontiersefficacysafetyanticoagulants
https://pubmed.ncbi.nlm.nih.gov/33694139/
Venous thromboembolism (VTE) is a major cause of morbidity and mortality throughout the world. Up to one half of patients who present with VTE will have an...
venous thromboembolismgeneticsthrombophilias
https://www.adventhealth.com/institute/adventhealth-research-institute/orthopedic-research/clinical-trials/optimal-dosing-low-dose-aspirin-chemoprophylaxis-venous-thromboembolism-following-total-joint
Our primary objective is to evaluate the efficacy of two different regimens, 81mg aspirin daily vs 81mg aspirin BID, in providing prophylaxis against...
low dose aspirinvenous thromboembolismoptimaldosingchemoprophylaxis
https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2022.885183/full
Background: The recent discovery of a venous thrombosis in the internal jugular vein of an astronaut has highlighted the need to predict the risk of venous t...
frontierssearchvenousendothelialbiomarkers
https://www.nasa.gov/directorates/esdmd/hhp/concern-of-venous-thromboembolism/
Note: The Concern of Venous Thromboembolism is historical and now a component of CV Risk.
venous thromboembolismconcernnasa
https://www.aafp.org/pubs/afp/issues/2008/0615/p1709.html
Venous thromboembolism is the leading cause of maternal death in the United States. Pregnancy is a risk factor for deep venous thrombosis, and risk is further...
venous thromboembolismpregnancyaafp
https://pubmed.ncbi.nlm.nih.gov/12814982/
Most deep vein thromboses (DVTs) start in the calf, and most probably resolve spontaneously. Thrombi that remain confined to the calf rarely cause leg symptoms...
natural historyvenous thromboembolism
https://www.pharmacytimes.com/view/venous-thromboembolism-and-cancer-multiple-treatment-agents
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
venous thromboembolismcancermultipletreatmentagents
https://www.heart.org/en/health-topics/venous-thromboembolism/risk-factors-for-vte
Venous thromboembolism (VTE) can affect men and women of all ages, races and ethnicities. People at the highest risk include those with cancer, having surgery...
american heart associationrisk factorsvenous thromboembolism
https://pubmed.ncbi.nlm.nih.gov/34146775/
IDH gene status did not appear as a significant risk factor for the development of venous thromboembolism (VTE) in our cohort of astrocytoma patients. Further...
venous thromboembolismidhmutationstatusdevelopment